Preclinical in Vitro and in vivo Assessment of a Novel Graphene Based MRI Contrast Agent

Keywords

according acute added administered adverse agent agents allow amounts amplify animal approximately assessed assessment association audience binding biological biology biomedical blood bolus brook button carbon characterization chelate chemical chosen clinical clinicians coefficient compromised concentration concentrations concern condition confidence contrast control days described detection developed development diagnostic diameter discovery disease dosages dose doses efficacious elsewhere engineering enhancement equilibrium evaluation expected extended fibrosis findings fold formulations fostered graphite greater histamine hydrophilic improve in vivo increasing indicate indicates injections insertion interaction intercalated ions jimmy leakage little major manganese materials medicine micro million mimic model molecular monitored need novel organ oxide partition pathology patients performance potential preparation prepared prevent procedures profile protein radiology rats recent release renal report residence restrictions safe safely safer safety scanner scientists sensitivity sequester sheets soluble solutions species stability stacks stony studied studies substantially summarizes symptoms synthesizing systemic table target terry therapeutic thermal tissue toxicity trace viscosity vitro voids water